Radiopharmaceuticals Third Party Logistics Market Size, Revenue, Forecast Report 2026 to 2035
Market Segmentation:
Radiopharmaceuticals Third-Party Logistics Market by Type -
• Diagnostic Radiopharmaceuticals
o PET Radiopharmaceuticals
o SPECT Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals
o Beta-Emitting Therapeutics
o Alpha-Emitting Therapeutics
o Other Therapeutic Radiopharmaceuticals
Radiopharmaceuticals Third-Party Logistics Market by Service -
• Transportation and Final-Mile Delivery
• Packaging and Pack-Out Services
• Temporary Storage and Cross-Docking
• Shipment Monitoring and Control-Tower Services
• Customs and Regulatory-Compliance Services
• Inventory and Order-Orchestration Services
• Returns and Reverse Logistics
• Other Services
Radiopharmaceuticals Third-Party Logistics Market by Radioisotope Half-Life -
• Ultra-Short Half-Life: Up to 2 Hours
• Short Half-Life: More than 2 Hours to 24 Hours
• Intermediate Half-Life: More than 24 Hours to 7 Days
• Long Half-Life: More than 7 Days
Radiopharmaceuticals Third-Party Logistics Market by Temperature Range -
• Controlled Room Temperature
• Refrigerated
• Frozen
• Deep-Frozen and Cryogenic
• Product-Specific Validated Conditions
Radiopharmaceuticals Third-Party Logistics Market by End-User -
• Radiopharmaceutical Manufacturers and Developers
• Isotope Producers
• Nuclear Pharmacies
• Contract Development and Manufacturing Organizations
• Contract Research Organizations and Research Institutes
• Hospitals and Cancer Centres
• Diagnostic Imaging Centres
• Other End Users
By Region-
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Radiopharmaceuticals Third-party Logistics Market Snapshot
Chapter 4. Global Radiopharmaceuticals Third-party Logistics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2026-2035
4.8. Global Radiopharmaceuticals Third-party Logistics Market Penetration & Growth Prospect Mapping (US$ Mn), 2025-2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/impact of AI on RADIOPHARMACEUTICALS THIRD-PARTY LOGISTICS MARKET Industry Trends
Chapter 5. Radiopharmaceuticals Third-party Logistics Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share by Type, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type:
5.2.1. Diagnostic Radiopharmaceuticals
5.2.1.1. PET Radiopharmaceuticals
5.2.1.2. SPECT Radiopharmaceuticals
5.2.2. Therapeutic Radiopharmaceuticals
5.2.2.1. Beta-Emitting Therapeutics
5.2.2.2. Alpha-Emitting Therapeutics
5.2.2.3. Other Therapeutic Radiopharmaceuticals
Chapter 6. Radiopharmaceuticals Third-party Logistics Market Segmentation 2: By Service, Estimates & Trend Analysis
6.1. Market Share by Service, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Service:
6.2.1. Transportation and Final-Mile Delivery
6.2.2. Packaging and Pack-Out Services
6.2.3. Temporary Storage and Cross-Docking
6.2.4. Shipment Monitoring and Control-Tower Services
6.2.5. Customs and Regulatory-Compliance Services
6.2.6. Inventory and Order-Orchestration Services
6.2.7. Returns and Reverse Logistics
6.2.8. Other Services
Chapter 7. Radiopharmaceuticals Third-party Logistics Market Segmentation 3: By Radioisotope Half-Life, Estimates & Trend Analysis
7.1. Market Share by Radioisotope Half-Life, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Radioisotope Half-Life:
7.2.1. Ultra-Short Half-Life: Up to 2 Hours
7.2.2. Short Half-Life: More than 2 Hours to 24 Hours
7.2.3. Intermediate Half-Life: More than 24 Hours to 7 Days
7.2.4. Long Half-Life: More than 7 Days
Chapter 8. Radiopharmaceuticals Third-party Logistics Market Segmentation 4: By Temperature Range, Estimates & Trend Analysis
8.1. Market Share by Temperature Range, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Temperature Range:
8.2.1. Controlled Room Temperature
8.2.2. Refrigerated
8.2.3. Frozen
8.2.4. Deep-Frozen and Cryogenic
8.2.5. Product-Specific Validated Conditions
Chapter 9. Radiopharmaceuticals Third-party Logistics Market Segmentation 5: By End Use Estimates & Trend Analysis
9.1. Market Share by End Use 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Target Indication (Disease Area):
9.2.1. Radiopharmaceutical Manufacturers and Developers
9.2.2. Isotope Producers
9.2.3. Nuclear Pharmacies
9.2.4. Contract Development and Manufacturing Organizations
9.2.5. Contract Research Organizations and Research Institutes
9.2.6. Hospitals and Cancer Centres
9.2.7. Diagnostic Imaging Centres
9.2.8. Other End Users
Chapter 10. Radiopharmaceuticals Third-party Logistics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Radiopharmaceuticals Third-party Logistics Market, Regional Snapshot 2025 & 2035
10.2. North America
10.2.1. North America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
10.2.1.1. The US
10.2.1.2. Canada
10.2.2. North America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2022-2035
10.2.3. North America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Service, 2022-2035
10.2.4. North America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Half-Life, 2022-2035
10.2.5. North America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Temperature Range, 2022-2035
10.2.6. North America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by End Use 2022-2035
10.3. Europe
10.3.1. Europe Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
10.3.1.1. Germany
10.3.1.2. The U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Portugal
10.3.1.7. Rest of Europe
10.3.2. Europe Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2022-2035
10.3.3. Europe Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Service, 2022-2035
10.3.4. Europe Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Half-Life, 2022-2035
10.3.5. Europe Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Temperature Range, 2022-2035
10.3.6. Europe Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by End Use 2022-2035
10.4. Asia Pacific
10.4.1. Asia Pacific Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. South Korea
10.4.1.5. Southeast Asia
10.4.1.6. Rest of Asia Pacific
10.4.2. Asia Pacific Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2022-2035
10.4.3. Asia Pacific Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Service, 2022-2035
10.4.4. Asia Pacific Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts By Radioisotope Half-Life, 2022-2035
10.4.5. Asia Pacific Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts By Temperature Range, 2022-2035
10.4.6. Asia Pacific Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by End Use 2022-2035
10.5. Latin America
10.5.1. Latin America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
10.5.1.1. Brazil
10.5.1.2. Argentina
10.5.1.3. Mexico
10.5.1.4. Colombia
10.5.1.5. Chile
10.5.1.6. Peru
10.5.1.7. Rest of Latin America
10.5.2. Latin America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2022-2035
10.5.3. Latin America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Service, 2022-2035
10.5.4. Latin America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Half-Life, 2022-2035
10.5.5. Latin America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Temperature Range, 2022-2035
10.5.6. Latin America Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by End Use 2022-2035
10.6. Middle East & Africa
10.6.1. Middle East & Africa Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2035
10.6.1.1. United Arab Emirates
10.6.1.2. Saudi Arabia
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Type, 2022-2035
10.6.3. Middle East & Africa Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Service, 2022-2035
10.6.4. Middle East & Africa Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Radioisotope Half-Life, 2022-2035
10.6.5. Middle East & Africa Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by Temperature Range, 2022-2035
10.6.6. Middle East & Africa Radiopharmaceuticals Third-party Logistics Market Revenue (US$ Million) Estimates and Forecasts by End Use 2022-2035
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Life Couriers
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. UPS
11.2.3. World Courier (Cencora)
11.2.4. American Expediting
11.2.5. AirNet II LLC
11.2.6. GTA Air Inc.
11.2.7. Lab Carriers
11.2.8. Kalitta Charters
11.2.9. NAF Pharma
11.2.10. PHSE S.r.l.
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Radiopharmaceuticals Third-Party Logistics Market Size is valued at USD 1,026.20 Mn in 2025 and is predicted to reach USD 4,315.69 Mn by the year 2035
Radiopharmaceuticals Third-Party Logistics Market is expected to grow at a 15.6% CAGR during the forecast period for 2026 to 2035.
UPS Healthcare–Marken–MNX; Cencora–World Courier; DHL Health Logistics; Kuehne+Nagel–QuickSTAT; FedEx Custom Critical; Cardinal Health; Telix–RLS Radiopharmacies; Curium; PharmaLogic; Jubilant Radiopharma; SOFIE Biosciences; Eckert & Ziegler; Movianto; Yourway; NTP Radioisotopes
Radiopharmaceuticals Third-Party Logistics Market is segmented into Type, Service, Radioisotope Half-Life, Temperature Range, End-user, and By Region
North America region is leading the Radiopharmaceuticals Third-Party Logistics Market.